title: What has changed in the treatment of ST-segment elevation myocardial infarction in Poland in 2003-2009? Data from the Polish Registry of Acute Coronary Syndromes (PL-ACS).
abstract: BACKGROUND
  A substantial progress has been made in Poland in the field of acute coronary syndromes (ACS) management over the last 10 years.
  
  
  OBJECTIVE
  To present the data from the Polish Registry of Acute Coronary Syndromes (PL-ACS) collected between 2003 and 2009. Changes in treatment strategies and outcomes in ST-segment myocardial infarction (STEMI) were analysed.
  
  
  METHODS
  We analysed patients enrolled to the PL-ACS Registry - a nationwide multicenter, prospective observational study of consecutive patients hospitalised with ACS in Poland.
  
  
  RESULTS
  Overall, 284,162 patients with ACS were enrolled in 512 centres including 88 invasive cardiology centres. The STEMI was diagnosed in 35-36% of these patients in 2003-2005, and this proportion remained stable at 30% to 32% in 2006-2009. The mean age of STEMI patients increased from 62.5 years in 2003 to 64.5 in 2009. During this period, women represented 32.7% to 34.6% of the STEMI patients. Proportion of patients presenting with pulmonary oedema or cardiogenic shock decreased with time, from 15.5% in 2003 to 8% in 2009. Delays to reperfusion tended to reduce over time: pain-to- -admission time was 240 min in 2005 and 229 min in 2009 and door-to-balloon time was 32 and 25 min in 2005 and 2009, respectively, with the delay being longer in the elderly population. The proportion of patients undergoing coronary angiography showed a constant increase, from 55% in 2003 to 84% in 2009. Percutaneous coronary intervention was performed in 51% and 78% of patients in 2003 and 2009, respectively. At the same time, the proportion of patients undergoing thrombolysis declined from 14% to 1%. Aspirin, beta-blocker, statin and ACE inhibitor use was constantly high, while nitrate use declined from 82% to 15%. The proportion of patients receiving clopidogrel increased from 40% to 97% over the analysed period. Significant reductions in mortality rates were observed: in-hospital mortality decreased from 11.9% to 6.4%; 30-day mortality from 13.5% to 9.6%; and 12-month mortality from 19.8% to 15.4% in 2003 and 2009, respectively. Invasive treatment strategy was associated with better in-hospital and long-term patient survival.
  
  
  CONCLUSIONS
  The PL-ACS Registry results demonstrate low short- and long-term mortality rates in STEMI patients, mainly due to frequent use of interventional strategy, satisfactory logistics and appropriate drug therapy used. As a consequence, hospitalisation time has shortened. However, there are several issues that need to be improved such as shortening of pre- -hospital delays and increasing the rate of invasive treatment in patients presenting with cardiogenic shock.
authors.affiliation: 3rd Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland. scchs@sum.edu.pl
authors.forename: Lech
authors.initials: L
authors.lastname: Poloński
authors.forename: Mariusz
authors.initials: M
authors.lastname: Gąsior
authors.forename: Marek
authors.initials: M
authors.lastname: Gierlotka
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Wilczek
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Kalarus
authors.forename: Jacek
authors.initials: J
authors.lastname: Dubiel
authors.forename: Witold
authors.initials: W
authors.lastname: Rużyłło
authors.forename: Waldemar
authors.initials: W
authors.lastname: Banasiak
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Opolski
authors.forename: Marian
authors.initials: M
authors.lastname: Zembala
mesh_terms: D017023:Coronary Angiography / Q000379:methods* / Q000592:standards / Q000639:trends; D004562:Electrocardiography / Q000379:methods; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000379:methods* / Q000592:standards / Q000639:trends; D011044:Poland / Q000453:epidemiology; D012042:Registries; D015912:Thrombolytic Therapy / Q000379:methods* / Q000592:standards / Q000639:trends; D016896:Treatment Outcome